About this episode

The episode discusses the urgent necessity of AI ethics in healthcare and business, featuring insights from Dr Nadia Morozova on building trust and responsible AI practices.

AI ethics has moved from theory to urgent necessity, especially as AI systems become embedded in healthcare, business decisions, and society at large. In this episode, Dr Andree Bates is joined by Dr Nadia Morozova , founder of Enriched Insights , to unpack what ethical AI really means in practice, and how organisations can innovate quickly without creating risk, bias, or governance failures. Nadia shares insights from the global conversation on AI ethics, including discussions at Davos, and explains why trust is becoming the true competitive advantage. She argues that organisations should use AI to build stronger, more open relationships with customers and stakeholders, where technology acts as an enabler rather than the centrepiece. The conversation then gets practical. Nadia outlines a human-centric framework for high-quality AI outcomes, covering accurate sampling, futureproofing (because models are trained on the past), data connectivity across sources, and responsible blending of human and synthetic data. She warns that leadership teams often treat AI as “magic”, assuming tools will solve complex problems like data harmonisation without the hard work of ontology…

People in this episode

Host: Dr Andree Bates

Guest: Dr Nadia Morozova

Topics covered

• AI ethics
• healthcare
• business decisions
• trust
• human-centric framework
• data governance

Mentioned in this episode

Organizations: Enriched Insights

Products: Zillow

More episodes of AI For Pharma Growth

• E216: When AI meets Cell Engineering · May 5, 2026 · 31 min
• E214: Beyond Copilot · April 21, 2026 · 39 min
• E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test · April 14, 2026 · 27 min
• E211: Precision Monitoring: How Digital Biomarkers Are Changing Medicine · March 31, 2026 · 33 min
• E210: Beyond Alzheimer’s: Scaling Digital Twins Across Disease Areas · March 24, 2026 · 32 min
• E209: Beyond Failure Prevention: How AI is Redesigning the Drug Discovery Pipeline · March 17, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the AI For Pharma Growth podcast page.